Works matching IS 10837159 AND DT 2021 AND VI 26 AND IP 11
Results: 42
Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation Brachytherapy.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1931, doi. 10.1002/onco.13980
- By:
- Publication type:
- Article
Validation of a Post‐Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2034, doi. 10.1002/onco.13969
- By:
- Publication type:
- Article
Implementation of an Embedded In‐Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1982, doi. 10.1002/onco.13968
- By:
- Publication type:
- Article
Revisiting EXTREME in the Immuno‐Oncology Era: How to Improve Its Outcomes.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 899, doi. 10.1002/onco.13966
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single‐Center Retrospective Study.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1951, doi. 10.1002/onco.13965
- By:
- Publication type:
- Article
Adherence to Endocrine Therapy and Racial Outcome Disparities in Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 910, doi. 10.1002/onco.13964
- By:
- Publication type:
- Article
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 927, doi. 10.1002/onco.13960
- By:
- Publication type:
- Article
The Courage to Prevail.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 988, doi. 10.1002/onco.13958
- By:
- Publication type:
- Article
First‐Line Durvalumab in Addition to Etoposide and Platinum for Extensive‐Stage Small Cell Lung Cancer: A U.S.‐Based Cost‐Effectiveness Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2013, doi. 10.1002/onco.13954
- By:
- Publication type:
- Article
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid‐Treated Oncology Patients.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2042, doi. 10.1002/onco.13953
- By:
- Publication type:
- Article
Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of Pathobiology.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 906, doi. 10.1002/onco.13947
- Publication type:
- Article
Knowledge About Risks, Benefits, and Curative Potential of Immunotherapy Among Patients with Advanced Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2090, doi. 10.1002/onco.13945
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population‐Based, Propensity Score‐Matched Cohort Study.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 974, doi. 10.1002/onco.13944
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2098, doi. 10.1002/onco.13939
- By:
- Publication type:
- Article
Hormone Receptor Subtype in Ductal Carcinoma in Situ: Prognostic and Predictive Roles of the Progesterone Receptor.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1939, doi. 10.1002/onco.13938
- By:
- Publication type:
- Article
Regarding "Surgical Metastasectomy in the Spine: A Review Article".
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2097, doi. 10.1002/onco.13937
- Publication type:
- Article
Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute–Designated Comprehensive Cancer Center.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1962, doi. 10.1002/onco.13936
- By:
- Publication type:
- Article
Health‐Related Quality of Life in Cancer Survivors with Chemotherapy‐Induced Peripheral Neuropathy: A Randomized Clinical Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2070, doi. 10.1002/onco.13933
- By:
- Publication type:
- Article
Successful Treatment of Afatinib Reversing Epidermal Growth Factor Receptor Exon19Deletion/G724S Mutation Resistance Guided by Protein‐Drug Docking.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1903, doi. 10.1002/onco.13932
- By:
- Publication type:
- Article
Physician Communication and Patient Understanding of Molecular Testing Terminology.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 934, doi. 10.1002/onco.13930
- By:
- Publication type:
- Article
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 950, doi. 10.1002/onco.13923
- By:
- Publication type:
- Article
Gefitinib Combined with Cetuximab for the Treatment of Lung Adenocarcinoma Harboring the EGFR–Intergenic Region (SEC61G) Fusion and EGFR Amplification.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1898, doi. 10.1002/onco.13921
- By:
- Publication type:
- Article
Nature versus Nurture: Investigating Racial Disparity in Advanced Prostate Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 904, doi. 10.1002/onco.13920
- By:
- Publication type:
- Article
Real‐World Clinical and Economic Outcomes in Selected Immune‐Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2002, doi. 10.1002/onco.13918
- By:
- Publication type:
- Article
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2053, doi. 10.1002/onco.13917
- By:
- Publication type:
- Article
Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2086, doi. 10.1002/onco.13916
- By:
- Publication type:
- Article
Clinical Outcomes, Treatment Toxicity, and Health Care Utilization in Older Adults with Aggressive Non‐Hodgkin Lymphoma.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 965, doi. 10.1002/onco.13915
- By:
- Publication type:
- Article
Association Between Caregiver‐Oncologist Discordance in Patient's Life Expectancy Estimates and Caregiver Perceived Autonomy Support by the Oncologist.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1992, doi. 10.1002/onco.13913
- By:
- Publication type:
- Article
Rapid Progression of Metastatic Pancreatic Adenocarcinoma During Platinum‐Based Therapy in a Patient Harboring a Pathogenic BRCA2 Germline Variant.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 916, doi. 10.1002/onco.13912
- By:
- Publication type:
- Article
First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 925, doi. 10.1002/onco.13911
- By:
- Publication type:
- Article
Validation of a Circulating Tumor DNA‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1971, doi. 10.1002/onco.13905
- By:
- Publication type:
- Article
Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2082, doi. 10.1002/onco.13903
- By:
- Publication type:
- Article
Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1919, doi. 10.1002/onco.13899
- By:
- Publication type:
- Article
Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and Anticoagulation.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2061, doi. 10.1002/onco.13897
- By:
- Publication type:
- Article
Ibritumomab Tiuxetan Radioimmunotherapy for Primary Gastrointestinal Follicular Lymphoma.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2079, doi. 10.1002/onco.13895
- By:
- Publication type:
- Article
EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 983, doi. 10.1002/onco.13892
- By:
- Publication type:
- Article
Sunitinib and Evofosfamide (TH‐302) in Systemic Treatment‐Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE‐1408 Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 941, doi. 10.1002/onco.13885
- By:
- Publication type:
- Article
Informed Consent 2021: The "Terms and Conditions" of the Research World.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 902, doi. 10.1002/onco.13882
- Publication type:
- Article
Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2021, doi. 10.1002/onco.13867
- By:
- Publication type:
- Article
Clinical Outcomes and Racial Disparities in Metastatic Hormone‐Sensitive Prostate Cancer in the Era of Novel Treatment Options.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 956, doi. 10.1002/onco.13848
- By:
- Publication type:
- Article
Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 919, doi. 10.1002/onco.13835
- By:
- Publication type:
- Article
COVID‐19 Pandemic and Cancer: The Importance of Early Palliative Care.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2094, doi. 10.1002/onco.13587
- By:
- Publication type:
- Article